Landmark clinical trial shows promise in quest for HIV vaccine

A successful HIV vaccine will likely require at least three components aimed at distinct viral regions. [iStockphoto]

In an exciting development, researchers at the Duke Human Vaccine Institute have made a major stride toward an effective HIV vaccine.

Their experimental vaccine candidate was able to trigger the production of powerful antibodies that can neutralise multiple strains of HIV in a small clinical trial.